Glinta-M Tablet 2.5 mg+850 mg is a combination oral antidiabetic medication containing Linagliptin (2.5 mg) and Metformin Hydrochloride (850 mg). This dual-action therapy is designed for the effective management of type 2 diabetes mellitus by addressing blood sugar control through two complementary mechanisms. Linagliptin, a DPP-4 inhibitor, enhances insulin secretion and suppresses glucagon release, while Metformin reduces hepatic glucose production and improves insulin sensitivity.

The combination provides comprehensive glycemic control, targeting both fasting and postprandial blood sugar levels. It is ideal for patients whose blood sugar is not sufficiently managed with lifestyle modifications or monotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Glinta-M Tablet 2.5 mg+850 mg is indicated for:

• Type 2 diabetes mellitus – To improve glycemic control when diet and exercise alone are insufficient.

• Combination therapy – Can be used alongside other antidiabetic medications under medical supervision.

• Prevention of complications – Maintaining stable blood sugar helps reduce the risk of long-term complications, including cardiovascular, renal, and nerve damage.

Mechanism of Action

The combination works through two complementary mechanisms:

• Linagliptin (DPP-4 inhibitor): Inhibits the DPP-4 enzyme, increasing incretin hormones, which stimulate insulin secretion after meals and suppress glucagon release, improving postprandial glucose control.

• Metformin Hydrochloride: Reduces liver glucose production, improves peripheral tissue sensitivity to insulin, and decreases intestinal glucose absorption, effectively controlling fasting blood sugar levels.

Together, they provide enhanced glycemic control with minimal risk of hypoglycemia.

Dosage and Administration

• Recommended dose: Usually one tablet twice daily with meals or as directed by a healthcare professional.

• Administration: Swallow the tablet whole with water; do not crush or chew to preserve the extended effect of Metformin.

• Monitoring: Regular blood sugar monitoring is advised to evaluate treatment effectiveness and adjust dosage as needed.

Precautions and Warnings

• Kidney or liver impairment: Use with caution; Metformin is contraindicated in severe renal impairment.

• Hypoglycemia: Risk is low when used alone but may increase if combined with insulin or sulfonylureas.

• Lactic acidosis: Rare but serious; seek medical attention if symptoms such as fatigue, muscle pain, or rapid breathing occur.

• Pregnancy and breastfeeding: Only use under medical supervision.

• Drug interactions: Inform your doctor about all medications being taken.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects may include:

• Gastrointestinal discomfort (nausea, diarrhea, abdominal pain)

• Headache or dizziness

• Nasopharyngitis (cold-like symptoms)

• Rare hypoglycemia, especially if used with other antidiabetic drugs

Proper adherence to prescribed dosage, diet, and lifestyle recommendations reduces the likelihood of side effects.

Storage

Store Glinta-M Tablet 2.5 mg+850 mg in a cool, dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.

Conclusion

Glinta-M Tablet 2.5 mg+850 mg by SK Pharma is an effective dual-action antidiabetic therapy for type 2 diabetes. By combining Linagliptin and Metformin, it provides comprehensive blood sugar control through complementary mechanisms, managing both fasting and postprandial glucose levels. With proper adherence, regular monitoring, and lifestyle modifications, it ensures safe and effective diabetes management while reducing the risk of long-term complications.